FK 960

Known as: FK-960, FK960 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2012
012319962012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
FK962 (N-(1-acetylpiperidin-4-yl)-4-fluorobenzamide) is a derivative of FK960 (N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide… (More)
Is this relevant?
2004
2004
We examined the effect of N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate (FK960), a novel anti-dementia drug, on… (More)
Is this relevant?
2003
2003
UNLABELLED This study used PET to measure the time course of the brain concentration of (18)F-labeled N-(4-acetyl-1-piperazinyl… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2002
2002
FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate] is a novel antidementia drug which has been demonstrated to have… (More)
Is this relevant?
2001
2001
We have demonstrated that FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel putative anti-dementia drug… (More)
Is this relevant?
2000
2000
The present study investigated the effect of N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate (FK960), a piperazine… (More)
Is this relevant?
1999
1999
The interactions of FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, with… (More)
Is this relevant?
1998
1998
Our previous studies have demonstrated that FK960 (FR59960; N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate), a novel… (More)
Is this relevant?
1997
1997
Our previous studies demonstrated that FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel antidementia… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1996
1996
With passive avoidance (PA), Morris water maze (WM) and eight-arm radial maze tasks, we evaluated the memory-enhancing action of… (More)
Is this relevant?